Royal Society of Chemistry, MedChemComm, 6(10), p. 913-925, 2019
DOI: 10.1039/c9md00183b
Full text: Unavailable
Galactopyranosides with aryl-aminopyrimidine moieties at O3 inhibit the tumor and immunity-related galectin-3 with high selectivity over other galectins.